Substitute for Raised H.B. No. 5270
Session Year 2016


To allow eligible patients to try investigational drugs, biological products or devices.

Introduced by:
Public Health Committee

 New today  2-4 days old  5 days & older
   Committee Actions
 PH Joint Fav. Rpt
 PH Vote Tally Sheet [pdf]
   Fiscal Notes
 Fiscal Note For File Copy 106
   Bill Analyses
 Bill Analysis For File Copy 106

*NOTE: Add to My Bills and Add Notes are cookie-based functions. If device cookies are cleaned, this information will be lost.

*NOTE: Add to My Bills and Add Notes are cookie-based functions. Browser must accept cookies from to function. If browser cookies are cleaned, bills will be lost.

Co-sponsors for Amendment LCO:

Bill History

 Date Action Taken
 4/1/2016Referred by House to Committee on Judiciary
 3/22/2016(LCO)File Number 106
 3/22/2016House Calendar Number 100
 3/22/2016Favorable Report, Tabled for the Calendar, House
 3/22/2016(LCO)Reported Out of Legislative Commissioners' Office
 3/16/2016(LCO)Referred to Office of Legislative Research and Office of Fiscal Analysis 03/21/16 5:00 PM
 3/8/2016(LCO)Filed with Legislative Commissioners' Office
 3/7/2016(PH)Joint Favorable
 2/19/2016Public Hearing 02/24
 2/17/2016Referred to Joint Committee on Public Health

Co-sponsors of HB-5270

Sen. Kevin D. Witkos, 8th Dist.
Sen. Art Linares, 33rd Dist.
Sen. Martin M. Looney, 11th Dist.
Rep. David Zoni, 81st Dist.
Rep. Henry J. Genga, 10th Dist.
Sen. Beth Bye, 5th Dist.
Rep. Vincent J. Candelora, 86th Dist.
Rep. Gayle J. Mulligan, 55th Dist.
Rep. Philip J. Miller, 36th Dist.
Rep. Theresa W. Conroy, 105th Dist.

NOTE: Please direct all inquiries regarding the status of bills to the Office of the House Clerk and/or Senate Clerks' Office.